Table 1.
Clinical and biological characteristics of the cohort at D0
Clinical | |
Age (years) (n = 153) < 40 years (%) [40–65] years > 65 years (%) |
70 [58;81] 7 35 59 |
Women (n = 153) (%) | 39 |
Weight (n = 130) (kg) | 80 ± 17 |
Height (n = 125) (m) | 1.70 [1.62;1.78] |
Body Mass index (n = 120) (kg/m2) | |
< 18.5 (%) [18.5–25] (%) [25–30] (%) ≥ 30 (%) |
28 [24;31] 3 27 43 27 |
Medical history (n = 153) | |
Hypertension (%) Diabetes (%) Chronic kidney disease (%) Active cancer (%) Active smoking (%) |
59 43 17 10 5 |
Intensive Care Unit (%) | 22 |
Severe case (%) | 82 |
Thoracic CT-Scanner staging (n = 151) (%) | |
Normal Minor (< 10%) Mild (10–50%) Severe (> 50%) |
17 7 61 16 |
Biological (D0) | |
C-reactive protein (n = 153) (mg/L) C-reactive protein > 5 mg/L |
81 [38;155] 97% |
Leukocytes (n = 153) (/mm3) >10,100/mm3 (%) <4600/mm3 (%) |
6180 [4650;9060] 19 24 |
Lymphocytes (n = 151) (/mm3) | 860 [655;1155] |
Hemoglobin (n = 153) (g/dL) | 12.3 [11.2;13.6] |
Platelets (n = 153) (× 1000/mm3) | 230 [165;301] |
Lactate Dehydrogenase (n = 153) (U/L) > 220 (%) |
342 [259;443] 87 |
D-Dimer (n = 141) (µg/L) > 500 (%) |
1009 [715;1878] 84 |
Albumin (n = 148) (g/L) < 32 (%) |
34 ± 5 30 |
Potassium (n = 153) (mmol/L) > 5.1 (%) < 2.5 (%) |
4.10 ± 0.47 2 9 |
Sodium (n = 153) (mmol/L) < 136 (%) |
139 [137;142] 14 |
Calcium (n = 153) (mmol/L) < 2.2 (%) |
2.10 [2.01;2.20] 72 |
Bicarbonate (n = 145) (mmol/L) < 22.1 (%) > 31 (%) |
25.5 [23.1;27.6] 17 7 |